Gene · 112398
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis. | Cancer Sci | 2023 | 37271497 | PubTator, text mining | PubMed |
| Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism. | Proc Natl Acad Sci U S A | 2023 | 37252972 | PubTator, text mining | PubMed |
| The UHRF1 protein is a key regulator of retrotransposable elements and innate immune response to viral RNA in human cells. | Epigenetics | 2023 | 37246786 | PubTator, text mining | PubMed |
| Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. | iScience | 2023 | 37235056 | PubTator, text mining | PubMed |
| Inflammatory and Infectious Disorders in Endocrine Pathology. | Endocr Pathol | 2023 | 37209390 | PubTator, text mining | PubMed |
| FDXR drives primary and endocrine-resistant tumor cell growth in ER+ breast cancer via CPT1A-mediated fatty acid oxidation. | Front Oncol | 2023 | 37207154 | PubTator, text mining | PubMed |
| Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective. | Front Endocrinol (Lausanne) | 2023 | 37206444 | PubTator, text mining | PubMed |
| Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease. | Front Pharmacol | 2023 | 37201028 | PubTator, text mining | PubMed |
| Identification of novel candidate genes in East Asian COPD patients by the functional summary-based imputation and the unified test for molecular signatures: a transcriptome-wide association study. | Chin Med J (Engl) | 2023 | 37185624 | PubTator, text mining | PubMed |
| Comprehensive Genetic Study of Malignant Cervical Paraganglioma. | Int J Mol Sci | 2023 | 37175927 | PubTator, text mining | PubMed |
| The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering. | Int J Mol Sci | 2023 | 37175732 | PubTator, text mining | PubMed |
| Molecular Characterization and Functional Analysis of Hypoxia-Responsive Factor Prolyl Hydroxylase Domain 2 in Mandarin Fish (Siniperca chuatsi). | Animals (Basel) | 2023 | 37174593 | PubTator, text mining | PubMed |
| Assessment of ferroptosis-associated gene signatures as potential biomarkers for differentiating latent from active tuberculosis in children. | Microb Genom | 2023 | 37163321 | PubTator, text mining | PubMed |
| Construction and validation of a novel prognostic signature for cutaneous melanoma based on ferroptosis-related genes. | Heliyon | 2023 | 37159694 | PubTator, text mining | PubMed |
| 10 Years of GWAS in intraocular pressure. | Front Genet | 2023 | 37124618 | PubTator, text mining | PubMed |
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis. | Heliyon | 2023 | 37123954 | PubTator, text mining | PubMed |
| The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management. | Int Braz J Urol | 2023 | 37115176 | PubTator, text mining | PubMed |
| Construction of Bone Hypoxic Microenvironment Based on Bone-on-a-Chip Platforms. | Int J Mol Sci | 2023 | 37108162 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37108109 | PubTator, text mining | PubMed |
| Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease. | Nephrol Dial Transplant | 2023 | 37096392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/112398/papers?page=9